Parameters
|
p-value of the interaction term treatment arm x factora
|
---|
Clinical characteristics
|
Location
|
0.26
|
Medical history
|
0.29
|
Baseline biomarkers
|
Human FGF (pg/mL)
|
0.28
|
PlGF (pg/mL)
|
0.57
|
SCF sR/c-kit (ng/mL)
|
0.27
|
sE-Selectin (ng/mL)
|
0.48
|
TSP-1 (μg/mL)
|
0.06
|
VEGF (ng/mL)
|
0.82
|
VEGF-C (ng/mL)
|
0.77
|
Variation (D8-D1)
|
Human FGF (pg/mL)
|
0.60
|
PlGF (pg/mL)
|
0.67
|
SCF sR/c-kit (ng/mL)
|
0.60
|
sE-Selectin (ng/mL)
|
0.62
|
TSP-1 (μg/mL)
|
0.28
|
VEGF (ng/mL)
|
0.45
|
VEGF-C (ng/mL)
|
0.93
|
- a P-value associated with better outcome when adding bevacizumab